1. Home
  2. XYLO vs SNES Comparison

XYLO vs SNES Comparison

Compare XYLO & SNES Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • XYLO
  • SNES
  • Stock Information
  • Founded
  • XYLO 1999
  • SNES 2004
  • Country
  • XYLO Israel
  • SNES United States
  • Employees
  • XYLO N/A
  • SNES N/A
  • Industry
  • XYLO
  • SNES Agricultural Chemicals
  • Sector
  • XYLO
  • SNES Industrials
  • Exchange
  • XYLO NYSE
  • SNES Nasdaq
  • Market Cap
  • XYLO 2.3M
  • SNES 2.3M
  • IPO Year
  • XYLO N/A
  • SNES 2016
  • Fundamental
  • Price
  • XYLO $3.15
  • SNES $3.16
  • Analyst Decision
  • XYLO
  • SNES Strong Buy
  • Analyst Count
  • XYLO 0
  • SNES 1
  • Target Price
  • XYLO N/A
  • SNES $10.00
  • AVG Volume (30 Days)
  • XYLO 17.6K
  • SNES 311.7K
  • Earning Date
  • XYLO 12-27-2024
  • SNES 11-12-2024
  • Dividend Yield
  • XYLO N/A
  • SNES N/A
  • EPS Growth
  • XYLO N/A
  • SNES N/A
  • EPS
  • XYLO N/A
  • SNES N/A
  • Revenue
  • XYLO $57,642,000.00
  • SNES $1,651,000.00
  • Revenue This Year
  • XYLO N/A
  • SNES $91.45
  • Revenue Next Year
  • XYLO N/A
  • SNES $101.31
  • P/E Ratio
  • XYLO N/A
  • SNES N/A
  • Revenue Growth
  • XYLO N/A
  • SNES 38.16
  • 52 Week Low
  • XYLO $2.70
  • SNES $1.90
  • 52 Week High
  • XYLO $10.43
  • SNES $21.40
  • Technical
  • Relative Strength Index (RSI)
  • XYLO 39.41
  • SNES 56.47
  • Support Level
  • XYLO $3.11
  • SNES $2.32
  • Resistance Level
  • XYLO $3.90
  • SNES $5.00
  • Average True Range (ATR)
  • XYLO 0.31
  • SNES 0.52
  • MACD
  • XYLO -0.05
  • SNES 0.13
  • Stochastic Oscillator
  • XYLO 2.94
  • SNES 35.66

About XYLO XYLO TECHNOLOGIES LTD

Xylo Technologies Ltd is an Israel-based medical device company. The company is engaged in the development, manufacturing, and marketing of direct vision systems for minimally invasive medical procedures and safety systems for drones and the electric vehicle (EV) sector. The key product of the company is the MUSE (Medigus Ultrasonic Surgical Endostapler) system is a single-use device for the incision-less treatment of GERD (gastroesophageal reflux disease), which is based on proprietary platform technology and know-how. The company operates in five segments namely, E-Commerce, Online Advertising & Internet Traffic Routing, Online Event Management, Corporate, and others. The company's geographical segments include the United States, Europe, Great Britain, Israel, Canada, Asia, and others.

About SNES SenesTech Inc.

SenesTech Inc is a United States-based biotech platform and research company engaged in developing technology for managing animal pest populations through fertility control. The company provides its solutions to the animal market, commercial markets, and food markets. It currently has two product lines of fertility control products: ContraPest and Evolve.

Share on Social Networks: